Accumulated evidence demonstrated that the CCL2-CCR2 axis promoted tumor growth, progression, and metastasis in many kinds of tumors, such as breast cancer, ovarian cancer, prostate cancer, gastric cancer and colorectal cancer by mediating tumor-associated macrophages (TAMs) recruitment [43–47]. The gene discussed is CCR2; the disease is prostate carcinoma.